Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Trellus Health PLC ( (GB:TRLS) ) just unveiled an update.
Trellus Health PLC announced during its Annual General Meeting that it has been granted preferred vendor status by a leading global contract research organization, reinforcing the value of its proprietary resilience methodology. The company is focusing on key commercial verticals such as pharmaceutical patient support programs and clinical trial services, while maintaining strong cash management by reducing its monthly cash burn. Trellus Health is also exploring potential commercial partnerships and fundraising options to extend its cash runway, indicating a strategic expansion in the pharmaceutical sector.
More about Trellus Health PLC
Trellus Health PLC is a healthcare company that provides value-based innovative solutions and services aimed at helping individuals with chronic conditions manage their health. The company offers Trellus Elevate®, a digital platform that integrates data analytics with personalized resilience programs to manage complex chronic conditions, with a focus on chronic gastrointestinal conditions like Inflammatory Bowel Disease (IBD). Trellus Health’s approach emphasizes emotional and physical health management, resulting in significant cost savings and improved health outcomes.
Average Trading Volume: 438,578
Technical Sentiment Signal: Sell
Current Market Cap: £1.05M
Learn more about TRLS stock on TipRanks’ Stock Analysis page.